Coegin Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2021
Coegin Pharma AB announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was SEK 20,000 compared to SEK 470,000 a year ago. Operating loss was SEK 10.113 million compared to SEK 1.824 million a year ago. Net loss was SEK 10.125 million compared to SEK 1.859 million a year ago. Basic loss per share from continuing operations was SEK 0.02 compared to SEK 0.49 a year ago.